Melinta Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Dan Wechsler, Melinta’s president and CEO, will present at the Jefferies 2018 Global Healthcare Conference in New York, NY. The presentation will take place on Weds., June 6 at 10:00 a.m. Eastern Time.